HIV p17 Gag 77-85 ( —— )

产品货号. M30373 CAS No. 147468-65-3

COA

Datasheet

HNMR

HPLC

MSDS

Handing Instructions

产品询价大包装询价加入购物车

产品名称

HIV p17 Gag 77-85
注意事项

本公司产品仅用于科研实验，不得用于人体或动物的临床与诊断
产品简述

HIV p17 Gag (77-85) is an attractive target for molecular intervention, because it is involved in the viral replication cycle at both the pre- and postintegration levels. In the present experiments, we targeted p17 by intracellularly expressing a cDNA encoding an Ab to p17.
产品描述

HIV p17 Gag (77-85) is an attractive target for molecular intervention, because it is involved in the viral replication cycle at both the pre- and postintegration levels. In the present experiments, we targeted p17 by intracellularly expressing a cDNA encoding an Ab to p17.
体外实验

——
体内实验

——
同义词

——
通路

Microbiology/Virology
靶点

HIV
受体

——
研究领域

——
适应症

——

Kan-Mitchell J, et al. Degeneracy and repertoire of the human HIV-1 Gag p17(77-85) CTL response. J Immunol. 2006 Jun 1;176(11):6690-701.

计算器

产品手册

关联产品

NPD4456

一种基于香豆素的 HIV-1 病毒蛋白 R (Vpr) 抑制剂，可抑制人类巨噬细胞的 Vpr 依赖性病毒感染。
BI 224436

BI 224436 是一种有效的、特异性的、HIV-1 非催化位点整合酶抑制剂 (NCINI)，针对不同的 HIV-1 实验室毒株的 EC50 为 11-27 nM。
BMS-488043

BMS-488043 is a novel and unique oral small molecule HIV fusion inhibitor that inhibits the attachment of Human Immunodeficiency Virus type 1 (HIV-1) to CD4(+) lymphocytes.BMS-488043 is used for the treatment of immune disorders, infections, and genitourinary disorders, and can be used in the study of HIV infect